MX9207171A - Preparaciones farmaceuticas a liberacion programada. - Google Patents

Preparaciones farmaceuticas a liberacion programada.

Info

Publication number
MX9207171A
MX9207171A MX9207171A MX9207171A MX9207171A MX 9207171 A MX9207171 A MX 9207171A MX 9207171 A MX9207171 A MX 9207171A MX 9207171 A MX9207171 A MX 9207171A MX 9207171 A MX9207171 A MX 9207171A
Authority
MX
Mexico
Prior art keywords
pharmaceutical preparations
scheduled release
ambroxol hydrochloride
delayed
preparations
Prior art date
Application number
MX9207171A
Other languages
English (en)
Inventor
Veronesi Paolo Alberto
Veronesi Anna Maria
Original Assignee
Therapicon Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon Srl filed Critical Therapicon Srl
Publication of MX9207171A publication Critical patent/MX9207171A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención concierne el procedimiento para la elaboración de preparaciones a liberación programada (retardada) de ambroxol clorhidrato. Las preparaciones farmacéuticas son elaboradas como microgránulos con un perfil de liberación retardada, adecuado para obtener niveles terapéuticos suficientes de ambroxol clorhidrato en el curso de las 24 horas recesivas a la administración en una sola toma de una dosis única.
MX9207171A 1991-12-11 1992-12-11 Preparaciones farmaceuticas a liberacion programada. MX9207171A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913318A IT1252185B (it) 1991-12-11 1991-12-11 Preparazioni farmaceutiche a liberazione programmata

Publications (1)

Publication Number Publication Date
MX9207171A true MX9207171A (es) 1994-01-31

Family

ID=11361308

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207171A MX9207171A (es) 1991-12-11 1992-12-11 Preparaciones farmaceuticas a liberacion programada.

Country Status (8)

Country Link
US (1) US6251429B1 (es)
EP (1) EP0546846B1 (es)
JP (1) JPH05320044A (es)
DE (1) DE69217020T2 (es)
ES (1) ES2099226T3 (es)
GR (1) GR3022416T3 (es)
IT (1) IT1252185B (es)
MX (1) MX9207171A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5070568A1 (es) * 1998-05-22 2001-08-28 Eurand Internatrional Spa Proceso de aplicacion de capas y aparato para efectuarlo
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
JP4644397B2 (ja) 2001-09-05 2011-03-02 信越化学工業株式会社 難溶性薬物を含む医薬用固形製剤の製造方法
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
CN1294907C (zh) * 2004-10-11 2007-01-17 成都拜特尔药业有限公司 盐酸氨溴索颗粒剂
CN101862305B (zh) * 2009-04-20 2014-05-07 北京德众万全药物技术开发有限公司 一种盐酸氨溴索缓释微丸及制备方法
JP6084355B2 (ja) * 2010-05-06 2017-02-22 大正製薬株式会社 アンブロキソール含有製剤粒子
CN105726489A (zh) * 2014-12-09 2016-07-06 澳美制药厂有限公司 盐酸氨溴索缓释制剂及其制备方法
CN105748443B (zh) * 2016-04-25 2018-09-11 华润双鹤利民药业（济南）有限公司 一种盐酸氨溴索缓释胶囊及其生产工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
ATE45106T1 (de) * 1984-05-18 1989-08-15 Univ Washington Verfahren zur einkapselung von teilchen oder von tropfen.
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JPH0761961B2 (ja) * 1986-06-24 1995-07-05 信越化学工業株式会社 被覆薬剤の製造方法
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
JP2000516222A (ja) * 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング 嚥下が容易な経口医薬組成物

Also Published As

Publication number Publication date
ITMI913318A1 (it) 1993-06-11
JPH05320044A (ja) 1993-12-03
GR3022416T3 (en) 1997-04-30
EP0546846B1 (en) 1997-01-22
EP0546846A1 (en) 1993-06-16
ES2099226T3 (es) 1997-05-16
US6251429B1 (en) 2001-06-26
DE69217020D1 (de) 1997-03-06
DE69217020T2 (de) 1997-07-31
ITMI913318A0 (it) 1991-12-11
IT1252185B (it) 1995-06-05

Similar Documents

Publication Publication Date Title
DE1001772T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
BR9403030A (pt) Processo para preparar medicamentos em forma de tabletes com liberação retardada de substância ativa
ES2002089T3 (es) Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos.
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
EA200000468A1 (ru) Терапевтическая композиция для введения толтеродина с контролируемым высвобождением
ES2053702T3 (es) Nuevas formulas de galenica de accion programada.
BR8801242A (pt) Processo de preparar uma composicao para fornecer uma quantidade efetiva de uma dose constante de um ingrediente ativo a um animal e a respectiva composicao
HUP0101427A2 (hu) Pezsgő készítmények
MX9307885A (es) Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
MX9207171A (es) Preparaciones farmaceuticas a liberacion programada.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
ATE329589T1 (de) Multipartikuläre bisoprolol formulierung
DE60320039D1 (de) Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
IT1244496B (it) Impiego terapeutico dei peptidi della somatostatina.
AR002724A1 (es) Peptido purificado fisiologicamente activo, sales de adicion de acido y sales de bases de dicho peptido, formas de dosificacion oral, intra-traqueal ynasal que comprenden a dicho peptido, formulacion farmaceutica que comprende a dicho peptido, usos de dicho peptido, metodo para la preparacion de dicha
GB1453034A (en) Pharmaceutical composition for treating spasticity
NO950950L (no) Farmasöytisk preparat
CO4930262A1 (es) Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica
ES2086526T3 (es) Aplicacion medicinal de m-csf.
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
ES2053683T3 (es) Forma de medicamento de aplicacion oral para el tratamiento de la hipertension una vez al dia con hidrocloruro de diltiazem.